Pennsylvanian Jury Awards $3.6 Million Verdict in Actos Trial

On February 12, 2015, a Philadelphia jury awarded a $3.6 million dollar verdict, which included a $1.3 million punitive damage award, to John Kristufek, a former Pennsylvanian educator, who alleged that pharma giant Takeda Pharmaceutical Co.’s Actos diabetes drug was the cause of his bladder cancer. Click here to read the full article: Takeda Ordered [...]

By | March 17th, 2015|Actos Diabetes Drug|Comments Off on Pennsylvanian Jury Awards $3.6 Million Verdict in Actos Trial

Takeda Held Responsible in First Federal Actos Bellwether Trial

After 34 days of trial, a Lafayette, Louisiana jury returned its verdict against Takeda and Lilly and ordered the PHARMA giants to pay $1.475 million in compensatory damages and $8 billion in punitive damages for injuries including bladder cancer to Terrance Allen, a hardware store manager, who took Actos for his diabetes treatment from 2004 [...]

By | April 8th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda Held Responsible in First Federal Actos Bellwether Trial

Actos Trial Underway in Louisiana

Terry Allen, a retired hardware store manager is the plaintiff in the case currently in trial against pharmaceutical giant Takeda, the manufacturer of Actos, the diabetes drug that Allen and his experts say caused him to have bladder cancer. (See In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299; Allen’s case is Allen v. Takeda Pharmaceuticals [...]

By | February 12th, 2014|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Actos Trial Underway in Louisiana

Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn.  Johnson & Johnson pled guilty to claims stemming from allegations that the giant pharmaceutical company knowingly marketed [...]

By | November 7th, 2013|Actos Diabetes Drug, Avandia Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Lipitor, Transvaginal Mesh|Comments Off on Big Pharma: Is Paying Big Fines More Profitable than Telling Doctors and Consumers the Truth in Marketing?

Another Plaintiffs Actos verdict, Another Verdict Thrown Out by Trial Judge

On September 26, 2013, a jury in Baltimore, Maryland, found that Takeda Pharmaceutical Co. did not properly warn Diep An, an ex-U.S. Army translator, and his doctor about the risks of its Actos diabetes drug and ordered the company to pay more than $1.7 million in damages.  Jurors also found that An, a thirty year [...]

By | September 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Another Plaintiffs Actos verdict, Another Verdict Thrown Out by Trial Judge

Second Actos Trial Begins

Lawyers for the family of Diep An told a Baltimore jury that drug giant Takeda’s failure to tell the whole truth about Actos role in the increased risk of cancer was the cause of death, as opening statements got under way. This case will provide further insight into how a jury views Takeda’s role in [...]

By | September 4th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Second Actos Trial Begins

Takeda’s Future after Losing Actos Patent

In 2012, Takeda’s profit dropped 53% and net profit was down 14% in the last nine months of 2012. Why? Because medical studies have demonstrated the causal connection between Takeda’s flagship diabetes drug Actos and bladder cancer and Takeda also lost its exclusivity patent on its foundation product diabetes treatment.  Actos accounted for more than [...]

By | August 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Takeda’s Future after Losing Actos Patent

Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post menopausal women with atypical femur fractures.  Currently there are over 10,000 pending cases in the [...]

By | May 28th, 2013|Actos Diabetes Drug, DePuy Hip Replacement, Drug and Medical Device Litigation, Fosamax Osteoporosis Drug, Transvaginal Mesh|Comments Off on Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?

Trial Judge Overturns $6.5 Million Cooper vs. Takeda Actos Verdict

Overturning a recent $6.5 million dollar verdict for Plaintiff Jack Cooper in Cooper vs. Takeda  (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court, Los Angeles), on May 1, 2013 the Hon. Kenneth Freeman granted two key Takeda’s motions leading to a reversal of the jury verdict of April 26, 2013. First, Judge Freeman [...]

By | May 1st, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on Trial Judge Overturns $6.5 Million Cooper vs. Takeda Actos Verdict

6.5 Million Dollar Jury Verdict in First Actos Trial

On April 26, 2013, a Los Angeles jury found Takeda liable for injuries including bladder cancer sustained by Jack Cooper, a former Pacific Bell telephone cable splicer, and returned a verdict of $6.5 million (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court, Los Angeles).  The jury deliberated eight days after the conclusion of [...]

By | April 26th, 2013|Actos Diabetes Drug, Drug and Medical Device Litigation|Comments Off on 6.5 Million Dollar Jury Verdict in First Actos Trial